Published on in Vol 11, No 1 (2022): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31925, first published .
Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2–Induced Changes for a Randomized Double-blind Controlled Trial

Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2–Induced Changes for a Randomized Double-blind Controlled Trial

Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2–Induced Changes for a Randomized Double-blind Controlled Trial

Journals

  1. Drabek M, Hodkinson D, Horvath S, Millar B, Pszczolkowski Parraguez S, Tench C, Tanasescu R, Lankappa S, Morriss R, Walsh D, Auer D. Brain connectivity-guided, Optimised theta burst transcranial magnetic stimulation to improve Central Pain Modulation in knee Osteoarthritis Pain (BoostCPM): protocol of a pilot randomised clinical trial in a secondary care setting in the UK. BMJ Open 2023;13(10):e073378 View
  2. Morriss R, Briley P, Webster L, Abdelghani M, Barber S, Bates P, Brookes C, Hall B, Ingram L, Kurkar M, Lankappa S, Liddle P, McAllister-Williams R, O’Neil-Kerr A, Pszczolkowski S, Suazo Di Paola A, Walters Y, Auer D. Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled trial. Nature Medicine 2024;30(2):403 View
  3. Briley P, Webster L, Lankappa S, Pszczolkowski S, McAllister-Williams R, Liddle P, Auer D, Morriss R. Trajectories of improvement with repetitive transcranial magnetic stimulation for treatment-resistant major depression in the BRIGhTMIND trial. npj Mental Health Research 2024;3(1) View
  4. Webster L, Boutry C, Thomson L, Abdelghani M, Barber S, Briley P, Kurkar M, Lankappa S, McAllister-Williams R, Di Paola A, Morriss R. Acceptability, tolerability and safety of the BRIGhTMIND trial: Connectivity-guided intermittent theta-burst stimulation versus F3- repetitive transcranial magnetic stimulation for treatment-resistant depression. Comprehensive Psychiatry 2025;136:152544 View
  5. Soleimani G, Conelea C, Kuplicki R, Opitz A, Lim K, Paulus M, Ekhtiari H. Targeting VMPFC‐amygdala circuit with TMS in substance use disorder: A mechanistic framework. Addiction Biology 2025;30(1) View
  6. Hodkinson D, Drabek M, Horvath S, Pszczolkowski S, Tench C, Tanasescu R, Lankappa S, Walsh D, Morriss R, Auer D. Accelerated intermittent theta burst transcranial magnetic stimulation of the dorsolateral prefrontal cortex for chronic knee osteoarthritis pain. Clinical Neurophysiology 2025 View